Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,948
Closed -$752K 2893
2026
Q1
$752K Sell
9,948
-14,713
-60% -$1.11M ﹤0.01% 1517
2025
Q4
$1.84M Sell
24,661
-1,710
-6% -$125K 0.01% 976
2025
Q3
$1.78M Sell
26,371
-5,124
-16% -$340K 0.01% 965
2025
Q2
$2.05M Buy
31,495
+16,149
+105% +$968K 0.01% 837
2025
Q1
$948K Sell
15,346
-162
-1% -$10.7K 0.01% 1155
2024
Q4
$1.12M Sell
15,508
-1,105
-7% -$86.3K 0.01% 1190
2024
Q3
$1.31M Buy
16,613
+667
+4% +$53.4K 0.01% 1113
2024
Q2
$1.21M Buy
+15,946
New +$1.2M 0.01% 1093

Other funds holding HOLX

Sanctuary Advisors's HOLX Position: Q2 2026 in Review

Sanctuary Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 9,948 shares — an estimated $752K sold.

Sanctuary Advisors first reported a position in HOLX in Q2 2024 and held it in 8 quarters. The position peaked at $2.05M in Q2 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Sanctuary Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 9,948 Hologic shares in Q2 2026, an estimated $752K.
  • Sanctuary Advisors first reported a position in Hologic in Q2 2024 and held it in 8 quarters.
  • Sanctuary Advisors's Hologic position peaked at $2.05M in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.